Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design-Reference-Cited by-同舟云学术

Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design

Published:2021-11-17 Issue: Volume: Page:
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum Psychopharmacol Clin Exp

Author:

Geers Lisanne M.¹^ORCID,Ochi Taichi²^ORCID,Vyalova Natalya M.³^ORCID,Losenkov Innokentiy S.³^ORCID,Paderina Diana Z.³⁴^ORCID,Pozhidaev Ivan V.³⁴^ORCID,Simutkin German G.³^ORCID,Bokhan Nikolay A.³⁴⁵^ORCID,Wilffert Bob¹²^ORCID,Touw Daniël J.¹⁶^ORCID,Loonen Anton J.M.²^ORCID,Ivanova Svetlana A.³⁵⁷^ORCID

Affiliation:

1. Department of Clinical Pharmacy and Pharmacology University of Groningen, University Medical Center Groningen Groningen The Netherlands

2. Pharmacotherapy, ‐ Epidemiology & ‐Economics University of Groningen, Groningen Research Institute of Pharmacy Groningen The Netherlands

3. Mental Health Research Institute Tomsk National Research Medical Center of the Russian Academy of Sciences Tomsk Russian Federation

4. National Research Tomsk State University Tomsk Russian Federation

5. Siberian State Medical University Tomsk Russian Federation

6. Department of Pharmaceutical Analysis University of Groningen, Groningen Research Institute of Pharmacy Groningen The Netherlands

7. National Research Tomsk Polytechnic University Tomsk Russian Federation

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hup.2826

Reference41 articles.

1. Biochemical, cellular, and pharmacological aspects of the multidrug transporter;Ambudkar S. V.;Annual Review of Pharmacology and Toxicology,1999

2. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta‐analysis of efficacy and tolerability;Anderson I. M.;Journal of Affective Disorders,2000

3. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders;Bauer M.;World Journal of Biological Psychiatry,2013

4. ABCB1 gene variants and antidepressant treatment outcome: A meta‐analysis;Breitenstein B.;American Journal of Medical Genetics Part B Neuropsychiatric Genetics,2015

5. Multidrug‐resistance gene (P‐glycoprotein) is expressed by endothelial cells at blood‐brain barrier sites;Cordon‐Cardo C.;Proceedings of the National Academy of Sciences of the United States of America,1989

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics and the Blood–Brain Barrier: A Whirlwind Tour of Potential Clinical Utility;Future Pharmacology;2024-09-05

2. Pilot Study of the DRD3, GHRL, FTO, LEPR, INSIG2, GSTP1, and ABCB1 Gene Expression in Peripheral Blood Leukocytes in Schizophrenic Patients with Metabolic Syndrome;Neurochemical Journal;2024-03

3. Which can Predict the Outcome of Antidepressants: Metabolic Genes or Pharmacodynamic Genes?;Current Drug Metabolism;2023-07

4. The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy;Genes;2023-05-16

5. ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the CAN‐BIND‐1 Study;Clinical Pharmacology & Therapeutics;2023-03-06